Hypoxia within a tumor acts as a strong selective pressure that promotes angiogenesis, invasion and metastatic spread. In this study, we used immune competent bone marrow chimeric mice and syngeneic orthotopic mammary cancer models to demonstrate that hypoxia in the primary tumor promotes pre-metastatic niche formation in secondary organs. Injection of mice with cell-free conditioned medium derived from hypoxic mammary tumor cells resulted in increased bone marrow-derived cell infiltration into the lung in the absence of a primary tumor and led to increased metastatic burden in mammary and melanoma experimental metastasis models. By characterizing the composition of infiltrating bone 
Abstract:
Hypoxia within a tumor acts as a strong selective pressure that promotes angiogenesis, invasion and metastatic spread. In this study, we used immune competent bone marrow chimeric mice and syngeneic orthotopic mammary cancer models to demonstrate that hypoxia in the primary tumor promotes pre-metastatic niche formation in secondary organs. Injection of mice with cell-free conditioned medium derived from hypoxic mammary tumor cells resulted in increased bone marrow-derived cell infiltration into the lung in the absence of a primary tumor and led to increased metastatic burden in mammary and melanoma experimental metastasis models. By characterizing the composition of infiltrating bone marrow-derived cells, we identified CD11b + /Ly6C med /Ly6G + myeloid and CD3 -/NK1.1 + immune cell lineages as key constituents of the pre-metastatic niche. Furthermore, the cytotoxicity of NK cells was significantly decreased, resulting in a reduced anti-tumor response that allowed metastasis formation in secondary organs to a similar extent as ablation of NK cells. In contrast, metastatic burden was decreased when active NK cells were present in pre-metastatic lungs. Together, our findings suggest that primary tumor hypoxia provides cytokines and growth factors capable of creating a pre-metastatic niche through recruitment of 
Introduction:
Hypoxia is a common feature and poor prognostic marker in several solid cancers (1). Cells respond to hypoxia through stabilization of the Hypoxia-inducible factor (Hif) transcription factor, resulting in the expression of genes involved in angiogenesis, invasion and metastasis
(1).
Hypoxia controls the composition of the tumor microenvironment, and the invasive and metastatic capacity of various cancers (2) . Factors capable of inducing bone marrowderived cell (BMDC) mobilization and recruitment to the tumor microenvironment include
Hif targets VEGF, angiopoietin-1, PIGF, PDGF-B and SDF1α (3) . Emerging evidence suggests primary tumor hypoxia and BMDCs drive pre-metastatic niche development in distant tissues, making them permissive for metastatic spread (4-5).
Pre-metastatic niche formation was first attributed to tumor-derived VEGF and PIGFinduced secretion of fibronectin from fibroblasts, promoting adhesion of VEGFR1 + hematopoietic progenitor cells (6) . Additional studies reported alternate mechanisms for premetastatic niche formation involving TNFα, TGFβ, lysyl-oxidase (LOX), MMP2, MMP9, CXCR4 and SDF1α among others (7) . Most of these are direct or indirect Hif targets and generally important in the metastatic process (1). While secretion of these factors by the primary tumor increases BMDCs in pre-metastatic organs, in depth characterization of the responsive BMDC lineages is lacking.
Here we report that conditioned medium containing monocyte chemotactic protein-1 (MCP-1/CCL2), derived from hypoxic mammary tumor cells, can induce pre-metastatic niche formation in the lungs of immune competent animals. Furthermore, we define lunginfiltrating, bone marrow-derived CD11b + /Ly6C med /Ly6G + myeloid cells and NK cells with reduced anti-tumour responses, which form a pre-metastatic niche conducive to increased metastatic burden independent of tumor type.
Materials and Methods:
Mice. Female C57Bl/6 mice were used at 8-14 weeks and purchased from the Walter and Eliza Hall Institute (Melbourne). C57Bl/6 NZeg-enhanced GFP (eGFP) mice were used as bone marrow-donors for chimeras generated as previously described (6, 8 Cell lines and conditioned media assays. The EO771 and PyMT mammary carcinoma and B16F10 melanoma cell lines were maintained as previously described (9) (10) , and infected with the pMSCV-Cherry/Luciferase lentiviral vector for sorting by flow cytometry.
Conditioned media was generated by filtering serum-free, phenol red-free low glucose A strong stabilization of Hif-1α protein was observed in both PyMT-WT and EO771
cells after 2 and 10 h hypoxia exposure compared to normoxia (Supplementary Figure 1A) . In contrast, Hif-2α protein was only marginally stabilized under hypoxia (Supplementary Figure   1A ). This suggests that formation of the pre-metastatic niche is driven by Hif-1α signaling in hypoxic tumor cells, although a contribution from exclusively Hif-2α-regulated genes cannot be excluded (11) .
Factors secreted from hypoxic tumor cells promote metastasis formation
To determine whether BMDC recruitment creates a pre-metastatic niche supportive of tumor cell colonization and metastatic outgrowth, we injected NCM or HCM derived from PyMT- Figure 2B) (7, (12) (13) , and thus hypoxia within the primary tumor may be the unifying process that drives pre-metastatic niche formation during tumorigenesis. MCP-1 is a member of the CC chemokine β-subfamily known to regulate the recruitment of inflammatory cells into tissues during inflammation and cancer (14) , and is 
NK cells in the pre-metastatic niche control metastasis formation
We next investigated other BMDC populations in the pre-metastatic niche. Author Manuscript Published OnlineFirst on July 2, 2012; DOI: 10.1158/0008-5472.CAN- As effector lymphocytes of the innate immune system, NK cells are important in regulating metastasis, but have decreased cytotoxicity in both cancer patients and tumorbearing mice (18) . We hypothesized that the increase in metastasis observed in HCM-treated mice could be explained by the decreased ability of NK cells to eliminate incoming tumor cells, and used two models of in vivo NK cell depletion to investigate this.
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